Company Intelligence

Miphic

Miphic enables the switch from long and expensive drug development to mitochondrial precision medicine that saves the lives of blood cancer patients.

In this profile

Quick Facts

  • Founded 2024
  • Headquarters Wilmington, Americas
  • Country Americas
  • Industry AI in Enterprise Software
  • Company Type Techstars Berlin Accelerator
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

Miphic enables the switch from long and expensive drug development to mitochondrial precision medicine that saves the lives of blood cancer patients.

Why It Matters

Miphic appears in the public Techstars Berlin Accelerator portfolio (open accelerator dataset).

Recent Developments

  1. 2024 Company founded

    Miphic was founded in 2024 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

Miphic enables the switch from long and expensive drug development to mitochondrial precision medicine that saves the lives of blood cancer patients.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe